Medpace Holdings, Inc. MEDP Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 21%-0.1pp | 21.1%-0.4pp | 21.5%+0.1pp | 21.4%+0.2pp | 21.2%0.0pp | |
| Net margin | 17.2%-0.6pp | 17.8%-0.5pp | 18.4%-0.4pp | 18.7%-0.6pp | 19.3%+0.1pp | |
| Returns | ||||||
| Return on equity | 77.3%+7.0pp | 70.2%-3.5pp | 73.7%-15.7pp | 89.4%+23.6pp | 65.8%+7.4pp | |
| Return on invested capital | 229.9%+9.9pp | 220%+60.1pp | 159.9%+41.7pp | 118.2%+9.3pp | 108.9%+12.0pp | |
| Efficiency | ||||||
| Asset turnover | 1.3×+0.1× | 1.2×0.0× | 1.2×0.0× | 1.3×+0.1× | 1.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 0.8×+0.1× | 0.7×+0.2× | 0.6×+0.1× | 0.4×-0.3× | 0.7×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×-0.1× | 0.3×-0.2× | 0.5×-0.4× | 0.9×+0.6× | 0.3×+0.1× | |
| Net debt / EBITDA | -0.9×-0.2× | -0.6×-0.4× | -0.3×-0.5× | 0.2×+0.8× | -0.6×+0.5× | |
| Per Share | ||||||
| Book value per share | $20.66+32.9% | $15.55+52.6% | $10.19+72.3% | $5.91-68.9% | $19.03-26.2% | |
| Valuation | ||||||
| Market capitalization | $13.63B-13.9% | $15.82B+9.5% | $14.44B+59.4% | $9.06B-2.4% | $9.28B-10.1% | |
| Price / earnings | 29.6×-5.5× | 35.1×+1.7× | 33.4×+11.7× | 21.7×-0.6× | 22.3×-3.2× | |
| Price / sales | 5.1×-1.2× | 6.3×+0.1× | 6.1×+2.1× | 4.1×-0.2× | 4.3×-0.6× | |
| Price / book | 22.8×-11.7× | 34.5×-14.7× | 49.2×-3.4× | 52.6×+36.9× | 15.6×+3.1× | |
| EV / EBITDA | 22.2×-5.3× | 27.5×+0.8× | 26.7×+8.6× | 18.1×-0.4× | 18.5×-2.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Medpace Holdings, Inc.'s ratios come from?
- Every ratio is computed from Medpace Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
